Search

Chemotherapy & Targeted Therapies Flash Cards

Chemotherapy & TargetedTherapies Flash Cards … Chemotherapy & TargetedTherapy Subcommittee …
Targeted Therapy Advanced Bootcamp

Targeted Therapy Advanced Bootcamp … interest, recommend targeted therapies, and manage toxicities related … with the approach and these therapies. This course is recommended …
ERAS Guidelines: Same Day Discharge

ERAS Guidelines: Same Day Discharg … episode, brought to you by the ERAs Subcommittee, which focuses … Enhanced Recovery after Surgery (ERAS). …
On-Demand Webinar: Optimizing Gynecologic Cancer Care in an Era of Chemotherapy Drug Shortages: SGO Updates and Recommendations

Gynecologic Cancer Care in an Era ofChemotherapy Drug Shortages: SGO Updates …
Key Concepts of Enhanced Recovery After Surgery. ERAS – How Well Do We Do It?

Enhanced Recovery After Surgery. ERAS – How Well Do We Do It … enhanced recovery after surgery (ERAS). In September 2022, the SGO …
ERAS Guidelines: Surgical Site Infection Bundle (SSI) Bundle

ERAS Guidelines: Surgical Site … ERAS Guidelines: Surgical Site …
Health Equity in the COVID-19 Era: Understanding the Data and Strategies to Support Vulnerable Populations

Health Equity in the COVID-19 Era: Understanding the Data and … Health Equity in the COVID-19 Era: Understanding the Data and …
Enhanced Recovery: The New Standard for Perioperative Care in Gynecologic Oncology: Implementing ERAS, the Nuts and Bolts

Gynecologic Oncology: Implementing ERAS, the Nuts and Bolts … Gynecologic Oncology: Implementing ERAS, the Nuts and Bolts …
Enhanced Recovery: The New Standard for Perioperative Care in Gynecologic Oncology: What is ERAS and how can it help us?

Gynecologic Oncology: What is ERAS and how can it help us … Gynecologic Oncology: What is ERAS and how can it help us …
Key Concepts of Enhanced Recovery After Surgery: ERAS–Why Do We Do It?

Enhanced Recovery After Surgery: ERAS–Why Do We Do It … Enhanced Recovery After Surgery: ERAS–Why Do We Do It …
Key Concepts of Enhanced Recovery After Surgery: ERAS – How Do We Do It?

Enhanced Recovery After Surgery: ERAS – How Do We Do It … Enhanced Recovery After Surgery: ERAS – How Do We Do It …
On-Demand Webinar: Chemotherapy Shortages: Root Causes, Regulatory Landscape, Legislative Process, and How the SGO is Navigating the Present and Future

On-Demand Webinar: Chemotherapy Shortages: Root Causes, Regulatory … root causes of the current chemotherapy shortage crisis and discuss … partnering organizations. Moderator: Angeles Alvarez Secord, MD …
Scientific Plenary V: Late Breaking Abstracts - Session 2

Moderators: …
Molecular Target: Folate Receptor Alpha (FOLR1)

Education Committee's 2024-2025 Chemotherapy and Immunotherapy Subcommittee …
Treatment Related Cardiotoxicity: Review and Management Companion Card

the Chemotherapy and Targeted Therapies Subcommittee , t his PDF …
Molecular Target: Human Epidermal Growth Factor Receptor 2 (HER2)

possible use of HER2 targeted therapies. Created by theChemotherapy and Immunotherapy Subcommittee …
Keeping up with the Chemos Series on Trastuzumab Deruxtecan ENHERTU®: Preparing to Give It (Pt. 1)

multidisciplinary panel reviews general information (such as when … rates in breast, line of therapy, and treatment options, before …
Keeping Up with the Chemos: CDK4/6 Inhibitors - Preparing to Give It (Part 1)

Tune in as the panel reviews general information (such as when …
Clinical Applications in Robotics: Colorectal Procedures

This 1.5-hour webinar, led by Gerald Feuer, MD, of Atlanta Gynecologic …
Keeping Up With the Chemos: CDK4/6 Inhibitors - Administration (Part 2)

Education Committee's 2024-2025 Chemotherapy and Immunotherapy Subcommittee … Immunotherapy Subcommittee Lead and Moderator …
Keeping Up With the Chemos: CDK4/6 Inhibitors - Follow Up (Part 3)

Education Committee's 2024-2025 Chemotherapy and Immunotherapy Subcommittee … Immunotherapy Subcommittee Lead and Moderator …
Keeping up with the Chemos Series on Trastuzumab Deruxtecan ENHERTU®: Monitoring Between Cycles (Pt. 3)

2023-2024 SGO Chemotherapy and TargetedTherapies Subcommittee Member, Moderato …
Keeping up with the Chemos Series on Trastuzumab Deruxtecan ENHERTU®: Administration (Pt. 2)

2023-2024 SGO Chemotherapy and TargetedTherapies Subcommittee Member, Moderato …
Fireside Chat: Critical Issues in Gyn Cancers & the Power of Shared Purpose

Moderator: …
Scientific Plenary II: Moving the Needle Together

Investigator’s Choice of Chemotherapy in FRα Positive Platinum-resistant …

SGO ConnectEd

Bookmark/Search this post

Pages

You are here

Search

Pages